|
Armor US Equity Index ETF | ARMR | Capital Link Global Fintech Leaders ETF | KOIN | Global X Founder-Run Companies ETF | BOSS | Gotham Enhanced 500 ETF | GSPY | Arrow DWA Tactical: Macro ETF | DWAT | Simplify Health Care ETF | PINK | Robo Global® Healthcare Technology and Innovation ETF | HTEC | Global X MLP ETF | MLPA | US Treasury 10 Year Note ETF | UTEN | Global X Genomics & Biotechnology ETF | GNOM |
Gross Expense Ratio*
0.60%
SEC 30 Day Yield (as of 12/30/22 )
--
Ann. Dividend/Yield
$0.592/2.76%
Ex-Dividend Date
12/27/2022
52-Wk Range
18.66 - 26.03
Fund Inception
02/10/2020
|
 Loading...
The chart is currently unavailable.
|
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Armor US Equity Index.The fund will normally invest at least 80% of its total assets in securities of the index. The index generally is comprised of one or more exchange-traded funds (“ETFs”), each of which is designed to track the performance of common stocks included in the following sectors of the U.S. equity market: communication services, consumer discretionary, consumer staples, energy, financials, health care, industrials, information technology, materials, real estate, and utilities.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Month |
-4.96% |
-5.14% |
-4.96% |
-5.14% |
3-Month |
+6.03% |
+6.02% |
+6.03% |
+6.02% |
6-Month |
-4.33% |
-4.49% |
-4.33% |
-4.49% |
Year-to-date |
-22.03% |
-22.06% |
-22.03% |
-22.06% |
1-Year |
-22.03% |
-22.06% |
-22.03% |
-22.06% |
3-Year |
-- |
-- |
-- |
-- |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
+1.89% |
+2.06% |
+1.89% |
+2.06% |
Inception Date: February 10, 2020
Performance Details
Total return reflects performance without adjusting for sales charges or the effects of taxation, but is adjusted to reflect all actual ongoing fund expenses and assumes reinvestment of dividends and capital gains. If adjusted, sales charges would reduce the performance quoted. Performance data quoted represents past performance, is no guarantee of future results, and may not provide an adequate basis for evaluating the performance potential of the product over varying market conditions or economic cycles. Current performance may be higher or lower than the performance data quotes. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost.
|
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
Market Return % (as of 12/31/2022) |
NAV Return % (as of 12/31/2022) |
1-Year |
-22.03% |
-22.06% |
-22.03% |
-22.06% |
5-Year |
-- |
-- |
-- |
-- |
10-Year |
-- |
-- |
-- |
-- |
Since Inception |
+1.89% |
+2.06% |
+1.89% |
+2.06% |
Inception Date: February 10, 2020
Cyclical |
10.88% |
8.89% |
1.71% |
0.02% |
0.26% |
Defensive |
38.46% |
26.23% |
0.43% |
11.80% |
Sensitive |
50.64% |
0.01% |
19.28% |
30.19% |
1.16% |
Portfolio Details
|
* represents an International company or one without a recognizable symbol.
Portfolio Details
|
|
|